Jonathan S. Edwards - Net Worth and Insider Trading
Jonathan S. Edwards Net Worth
The estimated net worth of Jonathan S. Edwards is at least $21 Million dollars as of 2024-11-13. Jonathan S. Edwards is the Director of Phathom Pharmaceuticals Inc and owns about 2,067,861 shares of Phathom Pharmaceuticals Inc (PHAT) stock worth over $21 Million. Details can be seen in Jonathan S. Edwards's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jonathan S. Edwards has not made any transactions after 2019-10-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jonathan S. Edwards
Jonathan S. Edwards Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan S. Edwards owns 1 companies in total, including Phathom Pharmaceuticals Inc (PHAT) .
Click here to see the complete history of Jonathan S. Edwards’s form 4 insider trades.
Insider Ownership Summary of Jonathan S. Edwards
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PHAT | Phathom Pharmaceuticals Inc | 2019-10-29 | director |
Jonathan S. Edwards Latest Holdings Summary
Jonathan S. Edwards currently owns a total of 1 stock. Jonathan S. Edwards owns 2,067,861 shares of Phathom Pharmaceuticals Inc (PHAT) as of October 29, 2019, with a value of $21 Million.
Latest Holdings of Jonathan S. Edwards
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals Inc | 2019-10-29 | 2,067,861 | 9.94 | 20,554,538 |
Holding Weightings of Jonathan S. Edwards
Jonathan S. Edwards Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan S. Edwards has made a total of 0 transactions in Phathom Pharmaceuticals Inc (PHAT) over the past 5 years. The most-recent trade in Phathom Pharmaceuticals Inc is the acquisition of 1,052,631 shares on October 29, 2019, which cost Jonathan S. Edwards around $20 Million.
Insider Trading History of Jonathan S. Edwards
- 1
Jonathan S. Edwards Trading Performance
GuruFocus tracks the stock performance after each of Jonathan S. Edwards's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan S. Edwards is 64.88%. GuruFocus also compares Jonathan S. Edwards's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan S. Edwards within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jonathan S. Edwards's insider trading performs compared to the benchmark.
Performance of Jonathan S. Edwards
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.78 | | | | | |
| Relative Return to S&P 500(%) | 6.35 | | | | | |
Jonathan S. Edwards Ownership Network
Ownership Network List of Jonathan S. Edwards
Ownership Network Relation of Jonathan S. Edwards
Jonathan S. Edwards Owned Company Details
What does Phathom Pharmaceuticals Inc do?
Who are the key executives at Phathom Pharmaceuticals Inc?
Jonathan S. Edwards is the director of Phathom Pharmaceuticals Inc. Other key executives at Phathom Pharmaceuticals Inc include Chief Operating Officer Azmi Nabulsi , CFO and CBO Molly Henderson , and 10 percent owner Takeda Pharmaceutical Co Ltd .
Phathom Pharmaceuticals Inc (PHAT) Insider Trades Summary
Over the past 18 months, Jonathan S. Edwards made no insider transaction in Phathom Pharmaceuticals Inc (PHAT). Other recent insider transactions involving Phathom Pharmaceuticals Inc (PHAT) include a net sale of 32,756 shares made by Molly Henderson , a net sale of 50,699 shares made by Terrie Curran , and a net sale of 3,703,703 shares made by Takeda Pharmaceutical Co Ltd .
In summary, during the past 3 months, insiders sold 0 shares of Phathom Pharmaceuticals Inc (PHAT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,798,059 shares of Phathom Pharmaceuticals Inc (PHAT) were sold and 7,500 shares were bought by its insiders, resulting in a net sale of 3,790,559 shares.
Phathom Pharmaceuticals Inc (PHAT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Phathom Pharmaceuticals Inc Insider Transactions
Jonathan S. Edwards Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan S. Edwards. You might contact Jonathan S. Edwards via mailing address: C/o Phathom Pharmaceuticals, Inc., 2150 E. Lake Cook Road, Suite 800, Buffalo Grove Il 60089.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
